Molecular mediators of hepatic steatosis and liver injury, J Clin Invest, vol.114, pp.147-52, 2004. ,
PPARs at the crossroads of lipid signaling and inflammation, Trends Endocrinol Metab, vol.23, pp.351-63, 2012. ,
Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat, Endocrinology, vol.137, pp.354-66, 1996. ,
Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice, J Clin Invest, vol.118, pp.829-867, 2008. ,
Integrated physiology and systems biology of PPAR?, Mol Metab, vol.3, pp.354-71, 2014. ,
Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol Cell Biol, vol.15, pp.3012-3034, 1995. ,
Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting, J Clin Invest, vol.103, pp.1489-98, 1999. ,
Peroxisome proliferator-activated receptor ? controls the hepatic CYP4A induction adaptive response to starvation and diabetes, J Biol Chem, vol.273, pp.31581-31590, 1998. ,
PPARalpha governs glycerol metabolism, J Clin Invest, vol.114, pp.94-103, 2004. ,
URL : https://hal.archives-ouvertes.fr/inserm-00546124
Nutrient-sensing nuclear receptors coordinate autophagy, Nature, vol.516, pp.112-127, 2014. ,
Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states, Cell Metab, vol.5, pp.426-463, 2007. ,
Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21, Cell Metab, vol.5, pp.415-440, 2007. ,
Inventing new medicines: The FGF21 story, Mol Metab, vol.3, pp.221-230, 2014. ,
Molecular mechanism of PPAR? action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease, J Hepatol, vol.62, pp.720-753, 2015. ,
The global NAFLD epidemic, Nat Rev Gastroenterol Hepatol, vol.10, pp.686-90, 2013. ,
From NAFLD to NASH to cirrhosis-new insights into disease mechanisms, Nat Rev Gastroenterol Hepatol, vol.10, pp.627-663, 2013. ,
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J Clin Invest, vol.115, pp.1343-51, 2005. ,
PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver, J Nutr, vol.141, pp.603-613, 2011. ,
Peroxisome proliferator-activated receptor ?-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis, J Biol Chem, vol.273, pp.29577-85, 1998. ,
Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice, Hepatology, vol.38, pp.123-155, 2003. ,
Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, Hepatology, vol.58, pp.1941-52, 2013. ,
PPAR? gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis, J Hepatol, vol.63, pp.164-73, 2015. ,
A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use, Nature, vol.502, pp.550-554, 2013. ,
Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes, J Lipid Res, vol.52, pp.873-84, 2011. ,
Peroxisome proliferator-activated receptor (PPAR)? activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPAR?, PPAR?, and their combination, Diabetes, vol.54, pp.3358-70, 2005. ,
Genome-wide analysis of PPARalpha activation in murine small intestine, Physiol Genomics, vol.30, pp.192-204, 2007. ,
Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding, Arch Biochem Biophys, vol.395, pp.246-52, 2001. ,
ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-? and PGC-1, Nat Med, vol.17, pp.1076-85, 2011. ,
Bioconductor: open software development for computational biology and bioinformatics, Genome Biol, vol.5, p.80, 2004. ,
Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets, Gastroenterology, vol.147, pp.1073-83, 2014. ,
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia, J Clin Invest, vol.124, pp.5175-90, 2014. ,
Transcriptional regulation of mitochondrial HMG-CoA synthase in the control of ketogenesis, Biochimie, vol.80, pp.803-809, 1998. ,
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease, Expert Opin Pharmacother, vol.15, pp.493-503, 2014. ,
Identification of a physiologically relevant endogenous ligand for PPARalpha in liver, Cell, vol.138, pp.476-88, 2009. ,
New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis, Cell Metab, vol.1, pp.309-331, 2005. ,
Altered lipid metabolism in residual white adipose tissues of Bscl2 deficient mice, PLoS ONE, vol.8, p.82526, 2013. ,
Fatty acids from fat cell lipolysis do not activate an inflammatory response but are stored as triacylglycerols in adipose tissue macrophages, Diabetologia, vol.58, pp.2627-2663, 2015. ,
Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver, Mol Cell Biol, vol.29, pp.6257-67, 2009. ,
Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia, Hepatology, vol.59, pp.858-69, 2014. ,
Lipolysis of triglyceride-rich lipoproteins generates PPAR ligands: evidence for an antiinflammatory role for lipoprotein lipase, Proc Natl Acad Sci, vol.100, pp.2730-2735, 2003. ,
Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice, Hepatology, vol.62, pp.1606-1624, 2015. ,
Fasting-induced G0/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids, J Hepatol, vol.63, pp.437-482, 2015. ,
Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding, Diabetes, vol.63, pp.4057-63, 2014. ,
Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation, Biochem J, vol.443, pp.165-71, 2012. ,
Glucose induces FGF21 mRNA expression through ChREBP activation in rat hepatocytes, FEBS Lett, vol.583, pp.2882-2888, 2009. ,
Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor ? to regulate metabolic hormone FGF21, Endocrinology, vol.155, pp.769-82, 2014. ,
Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21, Hepatology, vol.61, pp.1908-1927, 2015. ,
Liver X receptor negatively regulates fibroblast growth factor 21 in the fatty liver induced by cholesterol-enriched diet, J Nutr Biochem, vol.23, pp.785-90, 2012. ,
Role of white adipose lipolysis in the development of NASH induced by methionine-and choline-deficient diet, Biochim Biophys Acta, vol.1841, pp.1596-607, 2014. ,
Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH), Biochim Biophys Acta, vol.1842, pp.959-70, 2014. ,